Merck & Co., Inc. - MRK Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
News Sentiment
About
FAQ

Consensus Rating: Moderate Buy
Consensus Price Target: $131.25
Forecasted Upside: 4.35%
Number of Analysts: 12
Breakdown:
1 Sell Ratings
3 Hold Ratings
8 Buy Ratings
0 Strong Buy Ratings

^$125.78 As of 04/19/2024 01:00 AM ET

▲ +0.55 (0.44%)

1 month | 3 months | 12 months

Get New Merck & Co., Inc. Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for MRK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MRK

^$131.25

▲ +4.35% Upside Potential

This price target is based on 12 analysts offering 12 month price targets for Merck & Co., Inc. in the last 3 months. The average price target is $131.25, with a high forecast of $148.00 and a low forecast of $104.00. The average price target represents a 4.35% upside from the last price of $125.78.

Current Consensus is Moderate Buy

The current consensus among 12 polled investment analysts is to moderate buy stock in Merck & Co., Inc.. This Moderate Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
8 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

10/27/2022

0 strong buy ratings
8 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

1/25/2023

0 strong buy ratings
8 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

4/25/2023

0 strong buy ratings
8 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

7/24/2023

0 strong buy ratings
8 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

10/22/2023

0 strong buy ratings
8 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

1/20/2024

0 strong buy ratings
8 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

3/20/2024

0 strong buy ratings
8 buy ratings
3 hold ratings
1 sell ratings

Ratings as of

4/19/2024

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/18/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$135.00	Low
4/8/2024	Berenberg Bank	Boost Target	Buy ➝ Buy	$140.00 ➝ $143.00	Low
4/5/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$135.00	Low
3/28/2024	Truist Financial	Reiterated Rating	Buy ➝ Buy	$139.00 ➝ $142.00	N/A
3/27/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$135.00	Low
3/27/2024	Wells Fargo & Company	Boost Target	Equal Weight ➝ Equal Weight	$130.00 ➝ $135.00	Low
3/11/2024	Societe Generale	Downgrade	Hold ➝ Sell	$104.00	Low
2/29/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$135.00	Low
2/14/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$135.00	Low
2/5/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$135.00	Low
2/2/2024	Truist Financial	Boost Target	Buy ➝ Buy	$122.00 ➝ $139.00	Low
2/2/2024	UBS Group	Boost Target	Buy ➝ Buy	$135.00 ➝ $148.00	Low
2/2/2024	Wells Fargo & Company	Boost Target	Equal Weight ➝ Equal Weight	$125.00 ➝ $130.00	Low
2/2/2024	Barclays	Boost Target	Overweight ➝ Overweight	$135.00 ➝ $145.00	Low
1/23/2024	Barclays	Boost Target	Overweight ➝ Overweight	$130.00 ➝ $135.00	Low
1/9/2024	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$135.00	Low
1/4/2024	TD Cowen	Upgrade	Market Perform ➝ Outperform	$125.00 ➝ $135.00	Low
12/18/2023	Cantor Fitzgerald	Reiterated Rating	Overweight		Low
11/29/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$135.00	Low
11/15/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$135.00	Low
11/9/2023	Deutsche Bank Aktiengesellschaft	Initiated Coverage	Buy	$115.00	Low
10/27/2023	Morgan Stanley	Boost Target	Equal Weight ➝ Equal Weight	$115.00 ➝ $118.00	Low
10/27/2023	BMO Capital Markets	Upgrade	Market Perform ➝ Outperform	$132.00	Low
10/23/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$135.00	Low
10/20/2023	UBS Group	Upgrade	Neutral ➝ Buy	$117.00 ➝ $122.00	Low
10/11/2023	Morgan Stanley	Lower Target	Equal Weight ➝ Equal Weight	$116.00 ➝ $115.00	Low
10/6/2023	Truist Financial	Reiterated Rating	Buy ➝ Buy	$122.00	Low
10/2/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$135.00	Low
9/5/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$135.00	Low
8/22/2023	Cantor Fitzgerald	Reiterated Rating	Overweight ➝ Overweight	$135.00	Low
8/2/2023	Morgan Stanley	Boost Target	Equal Weight ➝ Equal Weight	$109.00 ➝ $116.00	N/A
8/2/2023	Truist Financial	Boost Target	Buy ➝ Buy	$116.00 ➝ $122.00	Low
7/20/2023	Truist Financial	Lower Target	Buy	$118.00 ➝ $116.00	Low
7/18/2023	BMO Capital Markets	Boost Target		$102.00 ➝ $113.00	Low
7/14/2023	HSBC	Initiated Coverage	Hold	$123.00	Low
5/1/2023	Barclays	Boost Target		$128.00 ➝ $130.00	Low
4/16/2023	BTIG Research	Downgrade	Buy ➝ Neutral		Low
4/13/2023	Citigroup	Upgrade	Neutral ➝ Buy	$105.00 ➝ $130.00	Low
4/11/2023	Guggenheim	Boost Target	Buy	$123.00 ➝ $124.00	Low
4/10/2023	Mizuho	Reiterated Rating	Buy	$130.00	Low
3/28/2023	Societe Generale	Downgrade	Buy ➝ Hold		Low
3/17/2023	Mizuho	Reiterated Rating	Buy	$130.00	Low
3/13/2023	Wells Fargo & Company	Downgrade	Overweight ➝ Equal Weight	$120.00 ➝ $115.00	Low
3/10/2023	Berenberg Bank	Boost Target	Buy	$125.00 ➝ $130.00	Low
3/9/2023	Guggenheim	Boost Target		$116.00 ➝ $123.00	Low
3/7/2023	Atlantic Securities	Boost Target	Overweight	$122.00 ➝ $127.00	Low
3/7/2023	Credit Suisse Group	Boost Target	Outperform	$125.00 ➝ $126.00	Low
3/7/2023	Mizuho	Initiated Coverage	Buy	$130.00	Low
3/6/2023	Jefferies Financial Group	Initiated Coverage	Buy	$125.00	Low
2/23/2023	JPMorgan Chase & Co.	Boost Target	Overweight	$120.00 ➝ $125.00	Low
2/22/2023	Wolfe Research	Upgrade	Peer Perform ➝ Outperform	$127.00	Low
2/13/2023	Credit Suisse Group	Boost Target	Outperform	$120.00 ➝ $125.00	Low
2/3/2023	Wells Fargo & Company	Lower Target	Overweight	$125.00 ➝ $120.00	Low
2/3/2023	Morgan Stanley	Lower Target	Equal Weight	$100.00 ➝ $99.00	Low
2/3/2023	SVB Leerink	Boost Target	Outperform	$120.00 ➝ $122.00	Low
2/3/2023	Truist Financial	Boost Target	Buy	$106.00 ➝ $118.00	N/A
1/23/2023	SVB Leerink	Boost Target	Outperform	$112.00 ➝ $120.00	Low
1/4/2023	Bank of America	Upgrade	Neutral ➝ Buy	$110.00 ➝ $130.00	Low
1/3/2023	Wells Fargo & Company	Boost Target	Overweight	$110.00 ➝ $125.00	Low
1/3/2023	Cowen	Boost Target		$108.00 ➝ $120.00	Low
12/20/2022	Barclays	Boost Target		$110.00 ➝ $128.00	Low
12/19/2022	Cantor Fitzgerald	Boost Target	Overweight	$120.00 ➝ $135.00	Low
12/15/2022	Mizuho	Boost Target		$100.00 ➝ $130.00	Low
11/17/2022	Credit Suisse Group	Initiated Coverage	Outperform	$120.00	Low
11/15/2022	Citigroup	Boost Target		$105.00	Low
11/1/2022	Guggenheim	Boost Target	Buy	$104.00 ➝ $111.00	Low
10/28/2022	Barclays	Boost Target	Overweight	$105.00 ➝ $110.00	Low
10/28/2022	Wells Fargo & Company	Boost Target	Overweight	$105.00 ➝ $110.00	Low
10/28/2022	Truist Financial	Boost Target	Buy	$103.00 ➝ $106.00	Low
10/28/2022	SVB Leerink	Boost Target	Outperform	$110.00 ➝ $112.00	Low
10/28/2022	Morgan Stanley	Boost Target	Equal Weight	$91.00 ➝ $100.00	Low
10/28/2022	Cantor Fitzgerald	Boost Target		$107.00 ➝ $120.00	Low
10/28/2022	Atlantic Securities	Boost Target	Overweight	$116.00 ➝ $122.00	Low
10/12/2022	Morgan Stanley	Lower Target	Equal Weight	$92.00 ➝ $91.00	Low
10/12/2022	Barclays	Boost Target		$101.00 ➝ $105.00	Low
10/11/2022	Atlantic Securities	Boost Target	Overweight	$110.00 ➝ $116.00	Low
10/11/2022	Truist Financial	Boost Target		$95.00 ➝ $103.00	Low
10/10/2022	Guggenheim	Upgrade	Neutral ➝ Buy	$104.00	Low
9/30/2022	SVB Leerink	Boost Target	Outperform	$109.00 ➝ $110.00	Low
9/14/2022	Berenberg Bank	Upgrade	Hold ➝ Buy	$95.00 ➝ $100.00	Low
9/12/2022	SVB Leerink	Boost Target	Outperform	$105.00 ➝ $109.00	Low
8/25/2022	Erste Group Bank	Upgrade	Hold ➝ Buy		Low
7/29/2022	Morgan Stanley	Boost Target	Equal Weight	$88.00 ➝ $92.00	Low
7/18/2022	UBS Group	Boost Target	Neutral	$76.00 ➝ $98.00	Low
7/13/2022	Atlantic Securities	Boost Target	Overweight	$105.00 ➝ $110.00	N/A
7/8/2022	Morgan Stanley	Boost Target	Equal Weight	$87.00 ➝ $88.00	N/A
7/6/2022	Daiwa Capital Markets	Upgrade	Neutral ➝ Buy	$89.00 ➝ $102.00	N/A
6/27/2022	Cowen	Boost Target	Market Perform	$95.00 ➝ $102.00	Low
6/27/2022	Cowen	Boost Target	Market Perform	$95.00 ➝ $102.00	Low
6/24/2022	Mizuho	Initiated Coverage	Buy	$100.00	Low
6/6/2022	SVB Leerink	Reiterated Rating	Outperform	$102.00	Low
4/21/2022	SVB Leerink	Lower Target	Outperform	$100.00 ➝ $97.00	Low
4/12/2022	Barclays	Boost Target	Overweight	$94.00 ➝ $97.00	Medium
4/6/2022	Morgan Stanley	Lower Target	Equal Weight	$82.00 ➝ $80.00	Low
4/6/2022	SVB Leerink	Lower Target	Outperform	$101.00 ➝ $100.00	Medium
4/1/2022	Mizuho	Initiated Coverage	Buy	$100.00	Medium
2/4/2022	SVB Leerink	Lower Target	Outperform	$102.00 ➝ $101.00	Medium
1/28/2022	JPMorgan Chase & Co.	Lower Target	Overweight	$100.00 ➝ $95.00	Low
12/23/2021	Mizuho	Initiated Coverage	Buy	$100.00	Low
12/17/2021	The Goldman Sachs Group	Initiated Coverage	Conviction-Buy	$93.00	High
12/16/2021	Daiwa Capital Markets	Initiated Coverage	Neutral	$70.00	Medium
12/13/2021	Mizuho	Reiterated Rating	Buy		High
12/13/2021	UBS Group	Downgrade	Buy ➝ Neutral	$98.00 ➝ $76.00	High
12/8/2021	Wells Fargo & Company	Initiated Coverage	Overweight	$90.00	Low
12/7/2021	Guggenheim	Downgrade	Buy ➝ Neutral	$98.00	Low
11/30/2021	SVB Leerink	Reiterated Rating	Buy		Low
11/29/2021	Morgan Stanley	Lower Target	Sell ➝ Equal Weight	$88.00 ➝ $82.00	High
11/29/2021	Citigroup	Downgrade	Buy ➝ Neutral	$105.00 ➝ $85.00	High
11/24/2021	Truist Financial	Boost Target	Buy	$92.00 ➝ $95.00	Low
11/18/2021	BMO Capital Markets	Initiated Coverage	Market Perform	$91.00	High
11/1/2021	Barclays	Boost Target	Overweight	$92.00 ➝ $94.00	Low
11/1/2021	Argus	Upgrade	Hold ➝ Buy	$110.00	Low
10/29/2021	Morgan Stanley	Boost Target	Equal Weight	$88.00 ➝ $90.00	Low
10/28/2021	Mizuho	Initiated Coverage	Buy	$99.00	High
10/22/2021	SVB Leerink	Boost Target	Outperform	$104.00 ➝ $105.00	Low
10/12/2021	Morgan Stanley	Boost Target	Equal Weight	$85.00 ➝ $88.00	Medium
10/10/2021	Berenberg Bank	Reiterated Rating	Hold	$86.00 ➝ $92.00	Low
10/8/2021	Barclays	Boost Target	Overweight	$87.00 ➝ $92.00	Low
10/4/2021	SVB Leerink	Boost Target	Outperform	$101.00 ➝ $104.00	Medium
10/1/2021	Mizuho	Initiated Coverage	Buy	$100.00	High
9/7/2021	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$90.00 ➝ $85.00	High
7/30/2021	SVB Leerink	Boost Target	Outperform	$99.00 ➝ $101.00	Low
7/27/2021	Truist Financial	Initiated Coverage	Buy	$76.79	Low
6/9/2021	JPMorgan Chase & Co.	Lower Target	Overweight	$105.00 ➝ $100.00	Medium
6/7/2021	Truist Financial	Lower Target	Buy	$96.00 ➝ $93.00	High
6/3/2021	SVB Leerink	Lower Target	Outperform	$102.00 ➝ $99.00	Medium
5/20/2021	Argus	Reiterated Rating	Buy ➝ Hold		Medium
4/30/2021	SVB Leerink	Lower Target	Outperform	$103.00 ➝ $102.00	Low
2/5/2021	Cantor Fitzgerald	Reiterated Rating	Overweight		Medium
12/6/2020	Mizuho	Reiterated Rating	Buy	$100.00	Low
11/10/2020	Sanford C. Bernstein	Reiterated Rating	Outperform	$95.00	Low
11/4/2020	JPMorgan Chase & Co.	Set Target	Neutral	€130.00	N/A
10/30/2020	The Goldman Sachs Group	Set Target	Sell	€102.00	N/A
10/29/2020	SVB Leerink	Boost Target	Outperform	$100.00 ➝ $103.00	Low
10/28/2020	Kepler Capital Markets	Set Target	Buy	€144.00	N/A
10/27/2020	JPMorgan Chase & Co.	Set Target	Neutral	€130.00	N/A
10/23/2020	Truist Financial	Initiated Coverage	Buy	$96.00	Low
10/21/2020	Morgan Stanley	Set Target	Neutral	€127.00	N/A
10/21/2020	Sanford C. Bernstein	Set Target	Neutral	€135.00	N/A
10/16/2020	JPMorgan Chase & Co.	Boost Target	Overweight	$98.00 ➝ $105.00	Low
10/13/2020	Barclays	Set Target	Neutral	€125.00	N/A
10/1/2020	Independent Research	Set Target	Buy	€139.00	N/A
9/29/2020	Berenberg Bank	Initiated Coverage	Hold	$88.00	Medium
9/28/2020	DZ Bank	Reiterated Rating	Buy		N/A
9/28/2020	The Goldman Sachs Group	Set Target	Sell	€102.00	N/A
9/22/2020	Mizuho	Reiterated Rating	Buy		Low
9/22/2020	The Goldman Sachs Group	Set Target	Sell	€100.00	N/A
9/21/2020	JPMorgan Chase & Co.	Set Target	Neutral	€130.00	N/A
9/18/2020	Independent Research	Set Target	Buy	€138.00	N/A
9/17/2020	Credit Suisse Group	Set Target	Buy	€140.00	N/A
9/16/2020	Sanford C. Bernstein	Set Target	Neutral	€115.00	N/A
9/16/2020	The Goldman Sachs Group	Set Target	Sell	€100.00	N/A
9/15/2020	JPMorgan Chase & Co.	Set Target	Neutral	€130.00	N/A
9/14/2020	Morgan Stanley	Set Target	Neutral	€127.00	N/A
8/27/2020	Kepler Capital Markets	Set Target	Buy	€130.00	N/A
8/25/2020	SVB Leerink	Boost Target	Outperform	$95.00 ➝ $100.00	Low
8/24/2020	The Goldman Sachs Group	Set Target	Sell	€100.00	N/A
8/10/2020	DZ Bank	Reiterated Rating	Buy		N/A
8/7/2020	Independent Research	Set Target	Buy	€124.00	N/A
8/7/2020	Kepler Capital Markets	Set Target	Buy	€130.00	N/A
8/7/2020	UBS Group	Set Target	Neutral	€108.00	N/A
8/7/2020	Sanford C. Bernstein	Set Target	Neutral	€115.00	N/A
8/7/2020	Credit Suisse Group	Set Target	Buy	€125.00	N/A
8/7/2020	Barclays	Set Target	Sell	€92.00	N/A
8/6/2020	Warburg Research	Set Target	Neutral	€108.00	N/A
8/6/2020	Nord/LB	Set Target	Neutral	€108.00	N/A
8/6/2020	Deutsche Bank Aktiengesellschaft	Set Target	Neutral	€110.00	N/A
8/6/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
8/6/2020	JPMorgan Chase & Co.	Set Target	Neutral	€110.00	N/A
8/4/2020	Royal Bank of Canada	Reiterated Rating	Hold		Medium
8/3/2020	The Goldman Sachs Group	Upgrade	Neutral ➝ Buy	$91.00 ➝ $105.00	High
7/31/2020	Mizuho	Reiterated Rating	Buy	$100.00	Low
7/29/2020	Warburg Research	Set Target	Neutral	€108.00	N/A
7/29/2020	JPMorgan Chase & Co.	Set Target	Neutral	€110.00	N/A
7/28/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
7/23/2020	JPMorgan Chase & Co.	Set Target	Neutral	€110.00	N/A
7/22/2020	DZ Bank	Reiterated Rating	Buy		N/A
7/22/2020	Credit Suisse Group	Set Target	Buy	€125.00	N/A
7/21/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
7/7/2020	JPMorgan Chase & Co.	Set Target	Neutral	€110.00	N/A
7/1/2020	Kepler Capital Markets	Set Target	Sell	€122.00	N/A
6/23/2020	Mizuho	Reiterated Rating	Buy	$100.00	Medium
6/23/2020	Morgan Stanley	Reiterated Rating	Buy	$89.00	Medium
6/12/2020	Wolfe Research	Downgrade	Outperform ➝ Peer Perform		Medium
6/10/2020	Kepler Capital Markets	Set Target	Buy	€122.00	N/A
6/10/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
6/8/2020	Sanford C. Bernstein	Set Target	Neutral	€115.00	N/A
6/4/2020	JPMorgan Chase & Co.	Set Target	Neutral	€110.00	N/A
6/3/2020	Barclays	Set Target	Sell	€90.00	N/A
6/2/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
5/29/2020	JPMorgan Chase & Co.	Set Target	Neutral	€110.00	N/A
5/27/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
5/21/2020	Deutsche Bank Aktiengesellschaft	Set Target	Neutral	€110.00	N/A
5/19/2020	DZ Bank	Reiterated Rating	Buy		N/A
5/18/2020	HSBC	Set Target	Neutral	€101.00	N/A
5/15/2020	Barclays	Set Target	Sell	€90.00	N/A
5/15/2020	Deutsche Bank Aktiengesellschaft	Set Target	Neutral	€110.00	N/A
5/15/2020	Credit Suisse Group	Set Target	Buy	€125.00	N/A
5/15/2020	Independent Research	Set Target	Buy	€122.00	N/A
5/15/2020	Nord/LB	Set Target	Neutral	€110.00	N/A
5/14/2020	Sanford C. Bernstein	Set Target	Neutral	€113.00	N/A
5/14/2020	JPMorgan Chase & Co.	Set Target	Neutral	€110.00	N/A
5/14/2020	UBS Group	Set Target	Neutral	€108.00	N/A
5/14/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
5/14/2020	Warburg Research	Set Target	Neutral	€106.00	N/A
5/7/2020	Warburg Research	Set Target	Neutral	€106.00	N/A
5/5/2020	Kepler Capital Markets	Set Target	Buy	€122.00	N/A
5/5/2020	Barclays	Set Target	Sell	€90.00	N/A
5/5/2020	Deutsche Bank Aktiengesellschaft	Set Target	Neutral	€110.00	N/A
5/5/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
5/5/2020	Credit Suisse Group	Set Target	Buy	€125.00	N/A
5/4/2020	DZ Bank	Reiterated Rating	Buy		N/A
5/4/2020	Credit Suisse Group	Reiterated Rating	Buy	$95.00	Low
5/1/2020	JPMorgan Chase & Co.	Set Target	Neutral	€110.00	N/A
4/29/2020	Guggenheim	Lower Target	Buy	$101.00 ➝ $93.00	Low
4/29/2020	Barclays	Lower Target	Overweight	$93.00 ➝ $90.00	Low
4/29/2020	SVB Leerink	Lower Target	Outperform	$98.00 ➝ $95.00	Low
4/16/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
4/15/2020	Sanford C. Bernstein	Set Target	Neutral	€113.00	N/A
4/13/2020	UBS Group	Lower Target	Buy	$96.00 ➝ $92.00	Low
4/7/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
4/2/2020	Morgan Stanley	Lower Target	Overweight	$97.00 ➝ $89.00	Medium
4/1/2020	Royal Bank of Canada	Lower Target	Sector Perform	$92.00 ➝ $89.00	Low
3/24/2020	Argus	Lower Target	Buy	$105.00 ➝ $95.00	Low
3/19/2020	Nord/LB	Set Target	Buy	€98.00	N/A
3/16/2020	DZ Bank	Reiterated Rating	Buy		N/A
3/13/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
3/9/2020	Independent Research	Set Target	Buy	€128.00	N/A
3/9/2020	UBS Group	Set Target	Neutral	€108.00	N/A
3/6/2020	Credit Suisse Group	Set Target	Buy	€125.00	N/A
3/5/2020	JPMorgan Chase & Co.	Set Target	Neutral	€110.00	N/A
3/5/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
3/5/2020	Sanford C. Bernstein	Set Target	Neutral	€120.00	N/A
3/5/2020	Barclays	Set Target	Sell	€94.00	N/A
3/4/2020	Kepler Capital Markets	Set Target	Buy	€119.00	N/A
3/2/2020	UBS Group	Set Target	Neutral	€108.00	N/A
2/27/2020	Barclays	Initiated Coverage	Overweight	$93.00	Medium
2/20/2020	Credit Suisse Group	Set Target	Buy	€125.00	N/A
2/18/2020	Deutsche Bank Aktiengesellschaft	Set Target	Neutral	€115.00	N/A
2/10/2020	DZ Bank	Reiterated Rating	Buy		N/A
2/10/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
2/6/2020	Royal Bank of Canada	Reiterated Rating	Sector Perform	$92.00	Low
2/6/2020	UBS Group	Lower Target	Buy	$99.00 ➝ $96.00	Low
2/5/2020	Mizuho	Reiterated Rating	Buy		High
2/5/2020	JPMorgan Chase & Co.	Set Target	Neutral	€110.00	N/A
1/28/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
1/23/2020	UBS Group	Boost Target	Buy	$94.00 ➝ $99.00	Low
1/21/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
1/21/2020	Nord/LB	Set Target	Neutral	€110.00	N/A
1/20/2020	Barclays	Set Target	Sell	€94.00	N/A
1/16/2020	Credit Suisse Group	Set Target	Buy	€125.00	N/A
1/8/2020	Cantor Fitzgerald	Reiterated Rating	Buy	$95.00	Medium
1/6/2020	Mizuho	Reiterated Rating	Buy	$100.00	High
1/6/2020	Royal Bank of Canada	Initiated Coverage	Sector Perform	$99.00	High
1/6/2020	JPMorgan Chase & Co.	Set Target	Neutral	€110.00	N/A
1/6/2020	Sanford C. Bernstein	Set Target	Neutral	€120.00	N/A
1/6/2020	Barclays	Set Target	Sell	€88.00	N/A
1/2/2020	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
12/31/2019	Barclays	Set Target	Sell	€88.00	N/A
12/25/2019	Barclays	Set Target	Sell	€88.00	N/A
12/19/2019	Barclays	Set Target	Sell	€88.00	N/A
12/9/2019	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
12/6/2019	JPMorgan Chase & Co.	Set Target	Neutral	€104.00	N/A
12/3/2019	The Goldman Sachs Group	Set Target	Sell	€94.00	N/A
11/27/2019	HSBC	Set Target	Neutral	€96.00	N/A
11/26/2019	UBS Group	Set Target	Neutral	€104.00	N/A
11/22/2019	DZ Bank	Reiterated Rating	Buy		N/A
11/19/2019	Nord/LB	Set Target	Neutral	€110.00	N/A
11/19/2019	JPMorgan Chase & Co.	Set Target	Neutral	€104.00	N/A
11/18/2019	Barclays	Set Target	Sell	€85.00	N/A
11/18/2019	Deutsche Bank Aktiengesellschaft	Set Target	Neutral	€104.00	N/A
11/15/2019	Credit Suisse Group	Set Target	Buy	€110.00	N/A
11/14/2019	Sanford C. Bernstein	Set Target	Neutral	€114.00	N/A
11/14/2019	UBS Group	Set Target	Neutral	€96.00	N/A
11/13/2019	Morgan Stanley	Boost Target	Overweight	$90.00 ➝ $95.00	Low
11/13/2019	Kepler Capital Markets	Set Target	Buy	€108.00	N/A
11/12/2019	Barclays	Set Target	Sell	€85.00	N/A
11/12/2019	Deutsche Bank Aktiengesellschaft	Set Target	Neutral	€104.00	N/A
11/11/2019	JPMorgan Chase & Co.	Set Target	Neutral	€100.00	N/A
11/4/2019	JPMorgan Chase & Co.	Set Target	Neutral	€100.00	N/A
10/30/2019	Mizuho	Boost Target	Buy	$97.00 ➝ $100.00	Medium
10/18/2019	Mizuho	Reiterated Rating	Buy	$97.00	Low
10/16/2019	Bank of America	Initiated Coverage	Neutral	$90.00	Low
10/14/2019	Barclays	Set Target	Sell	€82.00	N/A
10/10/2019	JPMorgan Chase & Co.	Set Target	Buy	$96.00	Low
10/9/2019	Sanford C. Bernstein	Set Target	Neutral	€114.00	N/A
10/4/2019	Nord/LB	Set Target	Neutral	€94.00	N/A
9/19/2019	Independent Research	Set Target	Neutral	€103.00	N/A
9/13/2019	Bank of America	Set Target	Neutral	€110.00	N/A
9/12/2019	JPMorgan Chase & Co.	Set Target	Neutral	€100.00	N/A
9/12/2019	Sanford C. Bernstein	Set Target	Neutral	€108.00	N/A
9/10/2019	Morgan Stanley	Set Target	Neutral	€96.00	N/A
9/8/2019	Mizuho	Reiterated Rating	Buy	$97.00	High
9/6/2019	Credit Suisse Group	Set Target	Buy	€110.00	N/A
9/3/2019	Societe Generale	Set Target	Buy	$105.00	Low
8/16/2019	SVB Leerink	Initiated Coverage	Outperform ➝ Outperform	$103.00	Low
8/15/2019	HSBC	Set Target	Neutral	€96.00	N/A
8/14/2019	DZ Bank	Reiterated Rating	Buy		N/A
8/14/2019	Barclays	Set Target	Sell	€82.00	N/A
8/9/2019	Deutsche Bank Aktiengesellschaft	Set Target	Neutral	€96.00	N/A
8/9/2019	Sanford C. Bernstein	Set Target	Neutral	€108.00	N/A
8/9/2019	JPMorgan Chase & Co.	Set Target	Neutral	€100.00	N/A
8/9/2019	Independent Research	Set Target	Neutral	€102.00	N/A
8/9/2019	Nord/LB	Set Target	Neutral	€94.00	N/A
8/8/2019	Credit Suisse Group	Set Target	Buy	€110.00	N/A
8/8/2019	UBS Group	Set Target	Neutral	€99.00	N/A
8/7/2019	Credit Suisse Group	Reiterated Rating	Buy	$95.00	Low
8/7/2019	Argus	Boost Target	Hold ➝ Buy	$105.00	Low
8/5/2019	Mizuho	Reiterated Rating	Buy	$97.00	Low
7/30/2019	Warburg Research	Set Target	Neutral	€103.00	N/A
7/23/2019	DZ Bank	Reiterated Rating	Buy		N/A
7/11/2019	Credit Suisse Group	Initiated Coverage	Buy	$95.00	Low
7/11/2019	Bank of America	Set Target	Buy	$97.00	High
7/2/2019	Mizuho	Initiated Coverage	Buy ➝ Buy	$97.00	Low
7/1/2019	Credit Suisse Group	Set Target	Buy	€110.00	N/A
6/21/2019	Bank of America	Boost Target	Buy	$91.00 ➝ $96.00	Medium
6/21/2019	Morgan Stanley	Boost Target	Overweight	$84.00 ➝ $90.00	Low
6/21/2019	Citigroup	Boost Target	Buy	$84.00 ➝ $95.00	Low
6/19/2019	Independent Research	Set Target	Neutral	€106.00	N/A
6/18/2019	Sanford C. Bernstein	Set Target	Neutral	€108.00	N/A
6/18/2019	Morgan Stanley	Set Target	Neutral	€96.00	N/A
6/17/2019	Kepler Capital Markets	Set Target	Buy	€108.00	N/A
6/14/2019	JPMorgan Chase & Co.	Boost Target	Overweight	$90.00 ➝ $93.00	Low
6/14/2019	Warburg Research	Set Target	Neutral	€103.00	N/A
6/4/2019	JPMorgan Chase & Co.	Set Target	Neutral	€100.00	N/A
6/4/2019	Sanford C. Bernstein	Set Target	Neutral	€108.00	N/A
5/28/2019	The Goldman Sachs Group	Initiated Coverage	Neutral ➝ Neutral	$85.00	Medium
5/27/2019	Barclays	Set Target	Sell	€82.00	N/A
5/22/2019	DZ Bank	Reiterated Rating	Buy		N/A
5/22/2019	Kepler Capital Markets	Set Target	Buy	€108.00	N/A
5/17/2019	Morgan Stanley	Set Target	Neutral	€96.00	N/A
5/17/2019	Nord/LB	Set Target	Neutral	€94.00	N/A
5/16/2019	Deutsche Bank Aktiengesellschaft	Set Target	Neutral	€96.00	N/A
5/15/2019	Credit Suisse Group	Set Target	Buy	€110.00	N/A
5/14/2019	Sanford C. Bernstein	Set Target	Neutral	€108.00	N/A
5/14/2019	Barclays	Set Target	Sell	€82.00	N/A
5/14/2019	Warburg Research	Set Target	Neutral	€103.00	N/A
5/14/2019	Independent Research	Set Target	Neutral	€106.00	N/A
5/14/2019	Kepler Capital Markets	Set Target	Buy	€110.00	N/A
5/13/2019	UBS Group	Set Target	Neutral	€104.00	N/A
5/13/2019	Atlantic Securities	Upgrade	Neutral ➝ Overweight		Low
5/13/2019	JPMorgan Chase & Co.	Set Target	Neutral	€100.00	N/A
5/9/2019	Deutsche Bank Aktiengesellschaft	Set Target	Neutral	€97.00	N/A
5/7/2019	JPMorgan Chase & Co.	Set Target	Neutral	€100.00	N/A
5/3/2019	Barclays	Set Target	Sell	€82.00	N/A
5/2/2019	UBS Group	Boost Target	Buy ➝ Buy	$87.00 ➝ $88.00	Medium
5/1/2019	Bank of America	Boost Target	Buy ➝ Buy	$90.00 ➝ $91.00	Low
5/1/2019	BMO Capital Markets	Boost Target	Market Perform ➝ Market Perform	$83.00 ➝ $84.00	Low
4/25/2019	UBS Group	Set Target	Neutral	€104.00	N/A

(Data available from 4/19/2019 forward)

News Sentiment Rating

0.89 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

29 very positive mentions
18 positive mentions
4 negative mentions
3 very negative mentions

Mentions as of

9/22/2023

41 very positive mentions
16 positive mentions
7 negative mentions
5 very negative mentions

Mentions as of

10/22/2023

14 very positive mentions
22 positive mentions
2 negative mentions
1 very negative mentions

Mentions as of

11/21/2023

42 very positive mentions
21 positive mentions
0 negative mentions
8 very negative mentions

Mentions as of

12/21/2023

44 very positive mentions
19 positive mentions
4 negative mentions
1 very negative mentions

Mentions as of

1/20/2024

56 very positive mentions
37 positive mentions
3 negative mentions
6 very negative mentions

Mentions as of

2/19/2024

49 very positive mentions
28 positive mentions
4 negative mentions
3 very negative mentions

Mentions as of

3/20/2024

57 very positive mentions
32 positive mentions
6 negative mentions
3 very negative mentions

Mentions as of

4/19/2024

Current Sentiment

Recent Stories by Sentiment

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Today's Range

Now: $125.78

$124.89

$126.12

50 Day Range

MA: $126.17

$120.54

$131.95

52 Week Range

Now: $125.78

$99.14

$133.10

Volume

8,377,080 shs

Average Volume

8,316,745 shs

Market Capitalization

$318.60 billion

P/E Ratio

898.43

Dividend Yield

2.46%

Beta

0.38

Frequently Asked Questions

What sell-side analysts currently cover shares of Merck & Co., Inc.?: The following Wall Street research analysts have issued research reports on Merck & Co., Inc. in the last twelve months: Barclays PLC, Berenberg Bank, BMO Capital Markets, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, HSBC Holdings plc, Morgan Stanley, Societe Generale, StockNews.com, TD Cowen, TheStreet, Truist Financial Co., UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for MRK.
What is the current price target for Merck & Co., Inc.?: 12 Wall Street analysts have set twelve-month price targets for Merck & Co., Inc. in the last year. Their average twelve-month price target is $131.25, suggesting a possible upside of 4.3%. UBS Group AG has the highest price target set, predicting MRK will reach $148.00 in the next twelve months. Societe Generale has the lowest price target set, forecasting a price of $104.00 for Merck & Co., Inc. in the next year.
View the latest price targets for MRK.
What is the current consensus analyst rating for Merck & Co., Inc.?: Merck & Co., Inc. currently has 1 sell rating, 3 hold ratings and 8 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for MRK.
What other companies compete with Merck & Co., Inc.?: Other companies that are similar to Merck & Co., Inc. include AbbVie, Johnson & Johnson, Pfizer, Bristol-Myers Squibb and Eli Lilly and Company. Learn More about companies similar to Merck & Co., Inc..
How do I contact Merck & Co., Inc.'s investor relations team?: Merck & Co., Inc.'s physical mailing address is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. The company's listed phone number is (908) 740-4000 and its investor relations email address is [email protected]. The official website for Merck & Co., Inc. is www.merck.com. Learn More about contacing Merck & Co., Inc. investor relations.

Merck & Co., Inc. - MRK Stock Price Target and Predictions

Analyst Price Target for MRK

Current Consensus is Moderate Buy

Past Monthly Recommendations

Latest Recommendations

News Sentiment Rating

0.89 (Buy)

News Sentiment Over Time

Current Sentiment

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Frequently Asked Questions

What sell-side analysts currently cover shares of Merck & Co., Inc.?

What is the current price target for Merck & Co., Inc.?

What is the current consensus analyst rating for Merck & Co., Inc.?

What other companies compete with Merck & Co., Inc.?

How do I contact Merck & Co., Inc.'s investor relations team?